BROWSE

AJOU Open Repository

Browsing by Ajou Author

researcher image email
김, 대중(Kim, Dae Jung) Currently indexed
[School of Medicine / Graduate School of Medicine] - [Endocrinology & Metabolism]

Author IDs

ORCID
0000-0003-1025-2044
ISNI
0000000472421912
WOS
AAJ-7518-2021
SCOPUS
57039350100
Research areas
Co-Researcher

Showing results 1 to 20 of 290

This table browses all dspace content
Pub YearTitleAuthor(s)
2024Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations김대중, 하경화
20232023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association김대중, 김혜진
2023Amphiregulin Induces iNOS and COX-2 Expression through NF- κ B and MAPK Signaling in Hepatic Inflammation강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2023Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia김대중, 하경화
2023Long-term Effectiveness of the National Diabetes Quality Assessment Program in South Korea김대중, 하경화
2023Diet quality partially mediates the association between ultraprocessed food consumption and adiposity indicators김대중, 하경화
2023Associations of updated cardiovascular health metrics, including sleep health, with incident diabetes and cardiovascular events in older adults with prediabetes: A nationwide population-based cohort study김대중, 하경화, 한승진
2023Ultra-Processed Food Consumption and Obesity in Korean Adults김대중, 하경화
2023Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study김대중
2023Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients김대중, 김혜진, 박범희, 이관우, 전자영, 한승진
2023Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study김대중, 하경화
2023Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes김대중, 하경화
2023Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study김대중, 하경화
2022Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2022Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study김대중, 김혜진, 이관우, 이나미, 전자영, 한승진
2022Psychometric Properties of the Korean Version of the Perceived Therapeutic Efficacy Scale for Physical Activity in Adults With Type 2 Diabetes김대중, 김춘자
2022Association of prediabetes with death and diabetic complications in older adults: The pros and cons of active screening for prediabetes김대중, 하경화
2022Maintaining Physical Activity Is Associated with Reduced Major Adverse Cardiovascular Events in People Newly Diagnosed with Diabetes김대중, 하경화
2022Screening for Prediabetes and Diabetes in Korean Nonpregnant Adults: A Position Statement of the Korean Diabetes Association, 2022김대중
2022Trends and Risk Factors of Metabolic Syndrome among Korean Adolescents, 2007 to 2018 (Diabetes Metab J 2021;45:880-9)김대중
1 2 3 4 5 6 7 8 9 10 11 15
  • License
    sherpa_romeo
    sherpa_juliet

OAK

Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312
Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved.
AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Guide 아주대학교 의학문헌정보센터